Ovarian cancer | Clinic-based follow-up | Telephone follow-up ± blood test | PIFU |
Low risk (<10% ROR, stage 1A/B fully staged) from end of treatment (surgery ± chemotherapy). Excluding fertility sparing surgery | Can be offered if declines PIFU for 2 years from end of treatment | Can be offered if declines PIFU for 2 years from end of treatment | Offer from end of treatment (after holistic needs assessment at 3 months) |
FIGO stages 1C–4 | For 3 years from end of treatment | Can be offered for years 4-5 from end of treatment | Not suitable |
PIFU, patient-initiated follow-up; ROR, risk of recurrence.